Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Preferred Dividend Payments: 2012-2024

Historic Preferred Dividend Payments for Ani Pharmaceuticals (ANIP) over the last 6 years, with Dec 2024 value amounting to $1.6 million.

  • Ani Pharmaceuticals' Preferred Dividend Payments fell 15.27% to $344,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 3.82%. This contributed to the annual value of $1.6 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per Ani Pharmaceuticals' latest filing, its Preferred Dividend Payments stood at $1.6 million for FY2024, which was down 0.00% from $1.6 million recorded in FY2023.
  • Ani Pharmaceuticals' Preferred Dividend Payments' 5-year high stood at $1.6 million during FY2022, with a 5-year trough of $190,000 in FY2021.
  • In the last 3 years, Ani Pharmaceuticals' Preferred Dividend Payments had a median value of $1.6 million in 2024 and averaged $1.6 million.
  • Data for Ani Pharmaceuticals' Preferred Dividend Payments shows a peak YoY soared of 755.26% (in 2022) over the last 5 years.
  • Ani Pharmaceuticals' Preferred Dividend Payments (Yearly) stood at $190,000 in 2021, then spiked by 755.26% to $1.6 million in 2022, then remained steady at $1.6 million in 2023, then remained steady at $1.6 million in 2024.